LFSC

Emerald$41.48-1.37 (-3.20%)
AUM $122.0MER 0.79%NAV $43.39Holdings —

Price Chart

Key Statistics

Previous Close

$42.85

Day Range

$41.48$42.41

52-Week Range

$32.96$48.44

Avg Volume

7.1K

Dividend Yield

—

Expense Ratio

0.79%

AUM

$122.0M

Shares Outstanding

2.8M

ETF Grades

?

Sector Breakdown

SectorWeight %
Healthcare100.00%

Country Allocation

CountryWeight %
United States100.00%

Fund Information

Issuer
Emerald
Category
Healthcare
Inception Date
Oct 21, 2024
Exchange
NASDAQ
Description
LFSC seeks to invest in innovative life sciences companies that are expected to create value and long-term growth. The actively managed fund relies on a specialized and experienced team to research complex life sciences companies. It invests in US equity securities identified to have growth potential that meet the criteria of technological advancement, market disruption, or artificial intelligence. The broad life science field includes biotechnology, pharmaceutical, medical diagnostics and devices, healthcare services and technologies, and synthetic biology. Stock selection employs an extensive 10-step research process that includes reviews of publicly available and third-party information, peer reviews, financial and valuation models, internal research, surveys, as well as interviews and contact with management, industry and medical professionals, supply chain, and collaboration within the investment team. The fund may invest up to 20% in foreign companies listed on a US exchange.

Similar ETFs

SymbolNameAUM
XLVState Street Health Care Select Sector SPDR ETF$46.92B
VHTVanguard Health Care ETF$20.80B
VTWOVanguard Russell 2000 ETF$16.80B
RWLInvesco S&P 500 Revenue ETF$10.01B
XBIState Street SPDR S&P Biotech ETF$9.64B

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund issued by Emerald that launched on Oct 21, 2024. It currently manages $122.0M in assets under management. The fund charges an expense ratio of 0.79%. It falls under the Healthcare category.

Top 10 holdings represent 56.8% of the fund

RankSymbolNameWeight %SharesMarket Value
1REPLReplimune Group Inc10.01%615,782$12.0M
2LIVNLivaNova PLC8.10%104,624$9.7M
3COGTCogent Biosciences Inc6.11%263,679$7.3M
4TVTXTravere Therapeutics Inc5.84%139,237$7.0M
5UTHRUnited Therapeutics Corp4.92%10,285$5.9M
6GHGuardant Health Inc4.78%37,447$5.7M
7MIRMMirum Pharmaceuticals Inc4.68%60,945$5.6M
8SYRESpyre Therapeutics Inc4.27%51,201$5.1M
9BLLNBilliontoone Inc4.08%53,727$4.9M
10TMDXTransMedics Group Inc4.01%49,805$4.8M
11SVRASavara Inc3.98%943,063$4.8M
12CYTKCytokinetics Inc3.96%91,841$4.8M
13MANEVeraDermics Inc3.85%36,764$4.6M
14ICUIICU Medical Inc2.98%20,197$3.6M
15AXSMAxsome Therapeutics Inc2.55%22,787$3.1M

Detailed Returns

PeriodReturnETF
1D
-3.20%
1W
-4.84%
1M
-0.04%
3M
-12.45%
6M
+7.67%
YTD
+15.45%
1Y
+14.17%
3Y
+66.30%
5Y
+66.30%

Moving Averages

20-Day MA

$44.20

Below 20-Day MA
50-Day MA

$43.68

Below 50-Day MA
200-Day MA

$41.23

Above 200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

$48.44

Current Price

$41.48

52-Week Low

$32.96

$32.96$48.44

Current Yield

—

Annual Dividend

—

Frequency

—

Last Ex-Date

—

Dividends

No dividend data available for this ETF.

Category Comparison

MetricLFSCHealthcare(212 ETFs)Active(633 ETFs)
Fund Info
Expense Ratio0.79%0.68%0.77%
AUM$122.0M$842.0M$392.4M
Dividend Yield—5.54%6.77%
Avg Volume7.1K257.4K167.9K
Holdings—12490
Performance
1-Month Return-2.36%-7.05%-7.08%
6-Month Return+7.78%-1.75%-8.40%
YTD Return+13.55%+2.72%-4.67%
1-Year Return—+0.26%-6.25%

Compare with Another ETF

Search for an ETF to compare with LFSC:

FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.